- Details
- Recorded Date: April 24, 2020 Joining Alicia Morgans is Lorelei Mucci and Philip Kantoff discussing a recently published article that addresses some of the potential overlaps between TMPRSS2 and COVID-19. Biographies: Philip Kantoff, MD., is the Chair, Department of Medicine; The George J. Bosl Chair Memorial Sloan Kettering Cancer Center. He is a board-certified medical oncologist and researcher...
|
- Details
- Recorded Date: April 26, 2020 In this conversation, Alicia Morgans speaks with Charles Drake, Professor of Medicine and Urology, and the head of GU Oncology at Columbia New York-Presbyterian in New York City about how he and his team have been influenced by COVID-19 in New York City. Biographies: Charles G. Drake, MD, Ph.D., Department of Medicine, Division of Hematology/Oncology, Co-Director, Can...
|
- Details
- Recorded Date: April 23, 2020 Oliver Sartor joins Alicia Morgans from New Orleans, Louisiana providing an update on the current healthcare environment during the COVID-19 pandemic At the Tulane Cancer Center, they have begun using new technology that allows rapid testing for COVID-19 in-house, receiving results in as little as five minutes. Biographies: A. Oliver Sartor, MD, Professor of Medicine...
|
- Details
- Recorded Date: April 24, 2020 William Oh joins Alicia Morgans providing an update to a previously recorded conversation from the center of the COVID-19 pandemic in New York City. As the city begins to pass the peak of the initial wave of the virus, Dr. Oh looks into the upcoming weeks and months as New York begins to loosen its restrictions. With many patients needing to be seen, the expectation i...
|
- Details
- Recorded Date: April 24, 2020 Jamie Landman and Monty Pal host a panel of experts to help sort through the information available online regarding kidney-associated complications with COVID-19. Together, Dena Battle, Kam Kalantar-Zadeh, Connie Rhee, and Michael Staehler address patients' concerns regarding kidney function and COVID-19. Biographies: Kamyar Kalantar-Zadeh, MD, MPH, Ph.D., Chief and P...
|
- Details
- Recorded Date: April 23, 2020 Thomas Powles from Barts Cancer Institute in London joins Alicia Morgans in a follow-up discussion providing an update to a previously recorded conversation on the current healthcare environment during the Coronavirus disease 2019 (COVID-19),(SARS-CoV-2) pandemic in the United Kingdom. Dr. Powles shares an aspirational perspective from London looking towards the futur...
|
- Details
- Recorded Date: April 18, 2020 Many of the tests used to diagnose and detect bladder cancer involve invasive procedures. Non-invasive testing options are equally effective and can be applied in this COVID-19 environment where we want to limit patients needing to come into the clinics for tests. In this discussion Neal Shore, Sima Porten, and Tom Nifong discuss Cxbladder a non-invasive, urine-based...
|
- Details
- Recorded Date: March 30, 2020 Edward (Ted) Schaeffer provides the urologist's perspective while answering patient questions on treatment considerations for localized prostate cancer in light of the COVID-19 crisis. Dr. Schaeffer provides insights into the National Comprehensive Cancer Network (NCCN) new patient guidelines on April 1, 2020. Biographies: Edward M. Schaeffer, MD, Ph.D., Chair, Depart...
|
- Details
- Recorded Date: March 30, 2020 The National Comprehensive Cancer Network (NCCN) released new guidelines, on April 1, 2020, directing cancer care during the COVID-19 crisis, Alicia Morgans and Edward Schaeffer address patient questions about their primary treatment concerns during this unprecedented time. Biographies: Edward M. Schaeffer, MD, Ph.D., Chair, Department of Urology, Feinberg School of M...
|
- Details
- Recorded Date: April 1, 2020 Stephen Freedland speaks to Alicia Morgans about the changes COVID-19 has brought to his clinical practice and research in Los Angeles, California. Dr. Freedland reflects on his clinical practice, noting that the halting of elective procedures has canceled all Benign Prostatic Hyperplasia procedures, while prostate cancer patients are being assessed on a case-by-case b...
|
